nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Skin striae—Bleomycin—melanoma	0.0264	0.0516	CcSEcCtD
Fludrocortisone—Cutaneous hypersensitivity—Docetaxel—melanoma	0.0193	0.0377	CcSEcCtD
Fludrocortisone—Trauma—Bleomycin—melanoma	0.0176	0.0344	CcSEcCtD
Fludrocortisone—Intracranial pressure increased—Carmustine—melanoma	0.0176	0.0343	CcSEcCtD
Fludrocortisone—Impaired healing—Carmustine—melanoma	0.017	0.0331	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Bleomycin—melanoma	0.0141	0.0276	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Vemurafenib—melanoma	0.0126	0.0246	CcSEcCtD
Fludrocortisone—Neoplasm—Vemurafenib—melanoma	0.0125	0.0245	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Carmustine—melanoma	0.0123	0.0241	CcSEcCtD
Fludrocortisone—Myopathy—Temozolomide—melanoma	0.0101	0.0197	CcSEcCtD
Fludrocortisone—Petechiae—Temozolomide—melanoma	0.00862	0.0168	CcSEcCtD
Fludrocortisone—Menstruation irregular—Docetaxel—melanoma	0.00851	0.0166	CcSEcCtD
Fludrocortisone—Amenorrhoea—Temozolomide—melanoma	0.00807	0.0157	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Docetaxel—melanoma	0.00793	0.0155	CcSEcCtD
Fludrocortisone—Oesophagitis—Dactinomycin—melanoma	0.00716	0.014	CcSEcCtD
Fludrocortisone—Injury—Bleomycin—melanoma	0.00664	0.013	CcSEcCtD
Fludrocortisone—Neoplasm—Carmustine—melanoma	0.00663	0.0129	CcSEcCtD
Fludrocortisone—Neoplasm—Temozolomide—melanoma	0.00641	0.0125	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Docetaxel—melanoma	0.00637	0.0124	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Carmustine—melanoma	0.00615	0.012	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Carmustine—melanoma	0.00612	0.0119	CcSEcCtD
Fludrocortisone—Erythema—Vemurafenib—melanoma	0.00606	0.0118	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Temozolomide—melanoma	0.00594	0.0116	CcSEcCtD
Fludrocortisone—Injury—Carmustine—melanoma	0.00579	0.0113	CcSEcCtD
Fludrocortisone—Vascular purpura—Temozolomide—melanoma	0.00575	0.0112	CcSEcCtD
Fludrocortisone—Amenorrhoea—Docetaxel—melanoma	0.00537	0.0105	CcSEcCtD
Fludrocortisone—Purpura—Temozolomide—melanoma	0.00534	0.0104	CcSEcCtD
Fludrocortisone—Testosterone Propionate—CYP17A1—melanoma	0.0053	0.182	CrCbGaD
Fludrocortisone—Myalgia—Vemurafenib—melanoma	0.00516	0.0101	CcSEcCtD
Fludrocortisone—Affect lability—Temozolomide—melanoma	0.00506	0.00988	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Vemurafenib—melanoma	0.00495	0.00966	CcSEcCtD
Fludrocortisone—Infection—Vemurafenib—melanoma	0.00492	0.00959	CcSEcCtD
Fludrocortisone—Mood swings—Temozolomide—melanoma	0.00487	0.00951	CcSEcCtD
Fludrocortisone—Muscular weakness—Carmustine—melanoma	0.0047	0.00917	CcSEcCtD
Fludrocortisone—Muscular weakness—Temozolomide—melanoma	0.00454	0.00886	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00451	0.0088	CcSEcCtD
Fludrocortisone—Abdominal distension—Temozolomide—melanoma	0.00448	0.00874	CcSEcCtD
Fludrocortisone—Fluid retention—Docetaxel—melanoma	0.00448	0.00873	CcSEcCtD
Fludrocortisone—Sweating increased—Temozolomide—melanoma	0.00433	0.00845	CcSEcCtD
Fludrocortisone—Oesophagitis—Docetaxel—melanoma	0.00431	0.00841	CcSEcCtD
Fludrocortisone—Neoplasm—Docetaxel—melanoma	0.00426	0.00832	CcSEcCtD
Fludrocortisone—Haemoglobin—Bleomycin—melanoma	0.00424	0.00828	CcSEcCtD
Fludrocortisone—Haemorrhage—Bleomycin—melanoma	0.00422	0.00824	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Carmustine—melanoma	0.00415	0.0081	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Temozolomide—melanoma	0.00401	0.00783	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Docetaxel—melanoma	0.00395	0.00771	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Docetaxel—melanoma	0.00377	0.00736	CcSEcCtD
Fludrocortisone—Haemoglobin—Carmustine—melanoma	0.0037	0.00723	CcSEcCtD
Fludrocortisone—Haemorrhage—Carmustine—melanoma	0.00368	0.00719	CcSEcCtD
Fludrocortisone—Erythema—Bleomycin—melanoma	0.00367	0.00717	CcSEcCtD
Fludrocortisone—Hypersensitivity—Vemurafenib—melanoma	0.00365	0.00712	CcSEcCtD
Fludrocortisone—Haemoglobin—Temozolomide—melanoma	0.00358	0.00698	CcSEcCtD
Fludrocortisone—Haemorrhage—Temozolomide—melanoma	0.00356	0.00695	CcSEcCtD
Fludrocortisone—Asthenia—Vemurafenib—melanoma	0.00355	0.00693	CcSEcCtD
Fludrocortisone—Erythema—Dactinomycin—melanoma	0.00343	0.00669	CcSEcCtD
Fludrocortisone—Erythema—Carmustine—melanoma	0.00321	0.00626	CcSEcCtD
Fludrocortisone—Myalgia—Bleomycin—melanoma	0.00313	0.0061	CcSEcCtD
Fludrocortisone—Headache—Vemurafenib—melanoma	0.0031	0.00605	CcSEcCtD
Fludrocortisone—Erythema—Temozolomide—melanoma	0.0031	0.00605	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Bleomycin—melanoma	0.003	0.00585	CcSEcCtD
Fludrocortisone—Oedema—Bleomycin—melanoma	0.003	0.00585	CcSEcCtD
Fludrocortisone—Infection—Bleomycin—melanoma	0.00298	0.00581	CcSEcCtD
Fludrocortisone—Myalgia—Dactinomycin—melanoma	0.00292	0.00569	CcSEcCtD
Fludrocortisone—Oedema—Dactinomycin—melanoma	0.0028	0.00546	CcSEcCtD
Fludrocortisone—Vertigo—Temozolomide—melanoma	0.00278	0.00543	CcSEcCtD
Fludrocortisone—Convulsion—Carmustine—melanoma	0.00278	0.00542	CcSEcCtD
Fludrocortisone—Infection—Dactinomycin—melanoma	0.00278	0.00542	CcSEcCtD
Fludrocortisone—Hypertension—Carmustine—melanoma	0.00277	0.0054	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00273	0.00533	CcSEcCtD
Fludrocortisone—Myalgia—Carmustine—melanoma	0.00273	0.00533	CcSEcCtD
Fludrocortisone—Convulsion—Temozolomide—melanoma	0.00268	0.00524	CcSEcCtD
Fludrocortisone—Hypertension—Temozolomide—melanoma	0.00268	0.00522	CcSEcCtD
Fludrocortisone—Myalgia—Temozolomide—melanoma	0.00264	0.00515	CcSEcCtD
Fludrocortisone—Oedema—Carmustine—melanoma	0.00262	0.00511	CcSEcCtD
Fludrocortisone—Infection—Carmustine—melanoma	0.0026	0.00507	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00255	0.00497	CcSEcCtD
Fludrocortisone—Oedema—Temozolomide—melanoma	0.00253	0.00494	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Temozolomide—melanoma	0.00253	0.00494	CcSEcCtD
Fludrocortisone—Infection—Temozolomide—melanoma	0.00251	0.0049	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Temozolomide—melanoma	0.00244	0.00477	CcSEcCtD
Fludrocortisone—Progesterone—CYP17A1—melanoma	0.00243	0.0837	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Carmustine—melanoma	0.00238	0.00465	CcSEcCtD
Fludrocortisone—Urticaria—Bleomycin—melanoma	0.00238	0.00465	CcSEcCtD
Fludrocortisone—Haemoglobin—Docetaxel—melanoma	0.00238	0.00464	CcSEcCtD
Fludrocortisone—Haemorrhage—Docetaxel—melanoma	0.00237	0.00462	CcSEcCtD
Fludrocortisone—Insomnia—Carmustine—melanoma	0.00237	0.00462	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Temozolomide—melanoma	0.0023	0.0045	CcSEcCtD
Fludrocortisone—Insomnia—Temozolomide—melanoma	0.00229	0.00446	CcSEcCtD
Fludrocortisone—Dexamethasone—CYP17A1—melanoma	0.00223	0.0765	CrCbGaD
Fludrocortisone—Hypersensitivity—Bleomycin—melanoma	0.00221	0.00431	CcSEcCtD
Fludrocortisone—Asthenia—Bleomycin—melanoma	0.00215	0.0042	CcSEcCtD
Fludrocortisone—Erythema—Docetaxel—melanoma	0.00206	0.00402	CcSEcCtD
Fludrocortisone—Hypersensitivity—Dactinomycin—melanoma	0.00206	0.00402	CcSEcCtD
Fludrocortisone—Urticaria—Temozolomide—melanoma	0.00201	0.00392	CcSEcCtD
Fludrocortisone—Asthenia—Dactinomycin—melanoma	0.00201	0.00392	CcSEcCtD
Fludrocortisone—Hypersensitivity—Carmustine—melanoma	0.00193	0.00376	CcSEcCtD
Fludrocortisone—Asthenia—Carmustine—melanoma	0.00188	0.00366	CcSEcCtD
Fludrocortisone—Hypersensitivity—Temozolomide—melanoma	0.00186	0.00364	CcSEcCtD
Fludrocortisone—Asthenia—Temozolomide—melanoma	0.00181	0.00354	CcSEcCtD
Fludrocortisone—Dexamethasone—NOS2—melanoma	0.00181	0.0624	CrCbGaD
Fludrocortisone—Convulsion—Docetaxel—melanoma	0.00179	0.00348	CcSEcCtD
Fludrocortisone—Hypertension—Docetaxel—melanoma	0.00178	0.00347	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK3—melanoma	0.00176	0.00383	CbGpPWpGaD
Fludrocortisone—Myalgia—Docetaxel—melanoma	0.00175	0.00342	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—melanoma	0.00172	0.00376	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CD4—melanoma	0.0017	0.00371	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—HIF1A—melanoma	0.00169	0.00368	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP1B1—melanoma	0.00169	0.058	CrCbGaD
Fludrocortisone—AR—FOXA1 transcription factor network—CDKN1B—melanoma	0.00169	0.00368	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Docetaxel—melanoma	0.00168	0.00328	CcSEcCtD
Fludrocortisone—Oedema—Docetaxel—melanoma	0.00168	0.00328	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CASP8—melanoma	0.00168	0.00367	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EDN1—melanoma	0.00167	0.00365	CbGpPWpGaD
Fludrocortisone—Infection—Docetaxel—melanoma	0.00167	0.00326	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK1—melanoma	0.00167	0.00364	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AURKA—melanoma	0.00165	0.0036	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL10—melanoma	0.00165	0.0036	CbGpPWpGaD
Fludrocortisone—Headache—Carmustine—melanoma	0.00164	0.0032	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CSF2—melanoma	0.00163	0.00356	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.00162	0.00353	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL4—melanoma	0.00161	0.00351	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CDKN1B—melanoma	0.0016	0.00349	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP1B1—melanoma	0.00159	0.0548	CrCbGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MDM2—melanoma	0.00159	0.00347	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—melanoma	0.00159	0.00346	CbGpPWpGaD
Fludrocortisone—Headache—Temozolomide—melanoma	0.00158	0.00309	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—RAC1—melanoma	0.00158	0.00344	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.00155	0.00338	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—melanoma	0.00154	0.00337	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP1B1—melanoma	0.00154	0.053	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Docetaxel—melanoma	0.00153	0.00299	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.00153	0.00333	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—melanoma	0.00153	0.00333	CbGpPWpGaD
Fludrocortisone—Insomnia—Docetaxel—melanoma	0.00152	0.00297	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—melanoma	0.00151	0.0033	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.00147	0.00321	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—melanoma	0.00147	0.0032	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HLA-A—melanoma	0.00146	0.00318	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—melanoma	0.00145	0.00317	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—melanoma	0.00145	0.00316	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—melanoma	0.00144	0.00314	CbGpPWpGaD
Fludrocortisone—Megestrol acetate—ABCB1—melanoma	0.00144	0.0495	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL4—melanoma	0.00142	0.00309	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP1—melanoma	0.0014	0.00306	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—melanoma	0.00139	0.00304	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—melanoma	0.00134	0.00292	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—melanoma	0.00134	0.00292	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—melanoma	0.00132	0.00287	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—melanoma	0.00129	0.00281	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—NOTCH1—melanoma	0.00128	0.0028	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—melanoma	0.00128	0.00279	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CLNS1A—melanoma	0.00128	0.00278	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—APC—melanoma	0.00126	0.00274	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Docetaxel—melanoma	0.00124	0.00242	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—melanoma	0.00124	0.0027	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—melanoma	0.00124	0.0027	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RB1—melanoma	0.00123	0.00269	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.00123	0.00268	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CTNNB1—melanoma	0.00123	0.00267	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MDM2—melanoma	0.00121	0.00263	CbGpPWpGaD
Fludrocortisone—Asthenia—Docetaxel—melanoma	0.00121	0.00235	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—melanoma	0.00118	0.00258	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—melanoma	0.00118	0.00257	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPS3—melanoma	0.00118	0.00257	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.00116	0.00253	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SKI—melanoma	0.00116	0.00253	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SNRPE—melanoma	0.00116	0.00253	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL10—melanoma	0.00115	0.0025	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—E2F1—melanoma	0.00114	0.00248	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—melanoma	0.00113	0.00245	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SOCS1—melanoma	0.00112	0.00245	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SKI—melanoma	0.00112	0.00244	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—ABCB1—melanoma	0.0011	0.0379	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CDKN2B—melanoma	0.0011	0.0024	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—melanoma	0.00109	0.0376	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—VDR—melanoma	0.00107	0.00234	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—melanoma	0.00107	0.00233	CbGpPWpGaD
Fludrocortisone—Headache—Docetaxel—melanoma	0.00105	0.00206	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—MDM2—melanoma	0.00105	0.00229	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RAC1—melanoma	0.00103	0.00226	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.00103	0.00224	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.001	0.00219	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MMP1—melanoma	0.001	0.00218	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—melanoma	0.000997	0.00217	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	0.000996	0.00217	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—melanoma	0.000987	0.00215	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDK2—melanoma	0.000983	0.00214	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—E2F1—melanoma	0.000974	0.00212	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IFNG—melanoma	0.000972	0.00212	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CLNS1A—melanoma	0.000968	0.00211	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—melanoma	0.000968	0.00211	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000967	0.00211	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000965	0.0021	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000955	0.00208	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000944	0.00206	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000934	0.00204	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ATM—melanoma	0.000933	0.00203	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDK4—melanoma	0.000929	0.00203	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000925	0.00202	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—melanoma	0.000915	0.002	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NPPA—melanoma	0.000907	0.00198	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000907	0.00198	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—melanoma	0.000907	0.00198	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	0.000903	0.00197	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—FAS—melanoma	0.000903	0.00197	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—melanoma	0.000895	0.0308	CrCbGaD
Fludrocortisone—Spironolactone—ABCB1—melanoma	0.000894	0.0307	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.00089	0.00194	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDKN1A—melanoma	0.000886	0.00193	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—melanoma	0.000884	0.00193	CbGpPWpGaD
Fludrocortisone—Prednisone—ALB—melanoma	0.000883	0.0304	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	0.000882	0.00192	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NPPA—melanoma	0.000875	0.00191	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000875	0.00191	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	0.00087	0.0019	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—melanoma	0.000863	0.00188	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000857	0.00187	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	0.000856	0.00187	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	0.000853	0.00186	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	0.000851	0.00186	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—melanoma	0.000849	0.00185	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SKI—melanoma	0.000848	0.00185	CbGpPWpGaD
Fludrocortisone—Prednisone—ABCB1—melanoma	0.000843	0.029	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—melanoma	0.000842	0.00184	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	0.000833	0.00182	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—ALB—melanoma	0.000826	0.0284	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—melanoma	0.000822	0.00179	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—melanoma	0.000817	0.00178	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000814	0.00178	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP8—melanoma	0.000814	0.00178	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—melanoma	0.000812	0.00177	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RB1—melanoma	0.000808	0.00176	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—melanoma	0.000805	0.00175	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—melanoma	0.0008	0.00174	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	0.000796	0.00174	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH1—melanoma	0.000793	0.00173	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000792	0.00173	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—melanoma	0.00079	0.00172	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—melanoma	0.000777	0.0267	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000773	0.00169	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.00077	0.00168	CbGpPWpGaD
Fludrocortisone—Betamethasone—ABCB1—melanoma	0.000761	0.0262	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	0.000761	0.00166	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—melanoma	0.000748	0.00163	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000733	0.0016	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000724	0.00158	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000724	0.00158	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—melanoma	0.000722	0.00157	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—melanoma	0.000718	0.00157	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	0.000717	0.00156	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000716	0.00156	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	0.000712	0.00155	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—melanoma	0.000699	0.00152	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—RB1—melanoma	0.000691	0.00151	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—melanoma	0.000689	0.0015	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MDM2—melanoma	0.000689	0.0015	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—melanoma	0.000685	0.00149	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.000679	0.00148	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—melanoma	0.000675	0.00147	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000675	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NPPA—melanoma	0.000664	0.00145	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HDAC2—melanoma	0.000664	0.00145	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000663	0.00145	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000641	0.0014	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000627	0.00137	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—melanoma	0.000616	0.00134	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	0.000612	0.00133	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.00061	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000601	0.00131	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—melanoma	0.0006	0.00131	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—melanoma	0.0006	0.00131	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—melanoma	0.000594	0.0204	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.000594	0.0013	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	0.000582	0.00127	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000579	0.00126	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—melanoma	0.000579	0.00126	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000579	0.00126	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.000576	0.00126	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000571	0.00124	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000562	0.00123	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000561	0.00122	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—melanoma	0.000554	0.00121	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00055	0.0012	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000549	0.0012	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPS3—melanoma	0.000547	0.00119	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SNRPE—melanoma	0.000538	0.00117	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SKI—melanoma	0.000538	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CDKN2B—melanoma	0.00053	0.00116	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.000523	0.00114	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000521	0.00114	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—melanoma	0.000521	0.0179	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—VDR—melanoma	0.000517	0.00113	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CDKN2B—melanoma	0.000511	0.00111	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000511	0.00111	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000509	0.00111	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—melanoma	0.000509	0.00111	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—melanoma	0.000508	0.00111	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—melanoma	0.000507	0.00111	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—VDR—melanoma	0.000498	0.00109	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000497	0.00108	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CDKN1A—melanoma	0.000496	0.00108	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000492	0.00107	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	0.000488	0.00107	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—melanoma	0.000484	0.0166	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—melanoma	0.000481	0.00105	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000481	0.00105	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.00048	0.00105	CbGpPWpGaD
Fludrocortisone—Testosterone—ALB—melanoma	0.000479	0.0165	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000477	0.00104	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PRKCA—melanoma	0.000477	0.00104	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000476	0.00104	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ERCC2—melanoma	0.000473	0.00103	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000471	0.00103	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000471	0.00103	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCB1—melanoma	0.000457	0.0157	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000455	0.000993	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	0.000447	0.000975	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000444	0.000969	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—melanoma	0.000443	0.000966	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCB1—melanoma	0.000443	0.0152	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000439	0.000957	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—melanoma	0.000437	0.000952	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000433	0.000945	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—melanoma	0.000427	0.000931	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000426	0.000929	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NPPA—melanoma	0.000421	0.000918	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000417	0.000908	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPS3—melanoma	0.000415	0.000904	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	0.000412	0.0009	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.00041	0.000894	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SKI—melanoma	0.000408	0.00089	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SNRPE—melanoma	0.000408	0.00089	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000399	0.000869	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—melanoma	0.000395	0.000862	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.00039	0.00085	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.00039	0.00085	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	0.000388	0.000845	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000386	0.000843	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—melanoma	0.000383	0.000836	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH1—melanoma	0.000382	0.000833	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—VDR—melanoma	0.000378	0.000824	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000371	0.00081	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000368	0.000803	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH1—melanoma	0.000368	0.000803	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—melanoma	0.00036	0.000786	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—melanoma	0.000352	0.000768	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—melanoma	0.000347	0.000757	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000338	0.000738	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000334	0.000728	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	0.000331	0.000722	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000327	0.000714	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NPPA—melanoma	0.000319	0.000697	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—melanoma	0.000309	0.000674	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HDAC2—melanoma	0.000308	0.000671	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	0.000279	0.000609	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000276	0.000603	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	0.000267	0.000583	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—melanoma	0.000263	0.000575	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CDKN2B—melanoma	0.000246	0.000536	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—VDR—melanoma	0.00024	0.000523	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HDAC2—melanoma	0.000234	0.000509	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PRKCA—melanoma	0.000221	0.000482	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ERCC2—melanoma	0.000219	0.000478	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MAPK3—melanoma	0.000211	0.000461	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—melanoma	0.000205	0.000448	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—melanoma	0.000198	0.000432	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CDKN2B—melanoma	0.000187	0.000407	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—VDR—melanoma	0.000182	0.000397	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH1—melanoma	0.000177	0.000386	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PRKCA—melanoma	0.000168	0.000366	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—melanoma	0.000167	0.000365	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ERCC2—melanoma	0.000166	0.000363	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—melanoma	0.00015	0.000328	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—melanoma	0.000142	0.000311	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH1—melanoma	0.000134	0.000293	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—melanoma	0.000127	0.000277	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MAPK3—melanoma	9.8e-05	0.000214	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—melanoma	9.53e-05	0.000208	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MAPK3—melanoma	7.44e-05	0.000162	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—melanoma	7.23e-05	0.000158	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—melanoma	6.61e-05	0.000144	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—melanoma	5.02e-05	0.000109	CbGpPWpGaD
